Cell therapy maker Sana Biotechnology is laying off staff, based on about half a dozen employee posts on LinkedIn in recent days, saying the company has gone through a restructuring.
Sana expects its first clinical data later this year — a key test of whether its so-called hypoimmune technology…
Click here to view original post
